Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps
International Journal of Molecular Sciences · 23.03.2023 · 24 (7) · 6094
DOI: 10.3390/ijms24076094 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2023. Verfasst von Florent Carsuzaa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Inflammation Tissus Epithéliaux et Cytokines (LITEC), UR15560, Université de Poitiers, F-86000 Poitiers, France. Hauptthemen laut MEDLINE: Nasal Polyps, Rhinitis, Sinusitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a typical type-2 inflammation involving several cytokines and is associated with epithelial cell dysfunction. Oncostatin M (OSM) (belonging to the interleukin(IL)-6 family) could be a key driver of epithelial barrier dysfunction. Therefore, we investigated the presence of OSM and IL-6 and the expression pattern of tight junctions (TJs) in the nasal tissue of CRSwNP patients and controls using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) and Western blotting. Then, their potential role in the epithelial barrier was evaluated in vitro in 27 different primary cultures of human nasal epithelial cells (HNECs) by measuring TJ expression and transepithelial electric resistance (TEER) with or without OSM or IL-6 (1, 10, and 100 ng/mL). The effect on ciliary beating efficiency was evaluated by high-speed videomicroscopy and on repair mechanisms with a wound healing model with or without OSM. OSM and IL-6 were both overexpressed, and TJ (ZO-1 and occludin) expression was decreased in the nasal polyps compared to the control mucosa. OSM (100 ng/mL) but not IL-6 induced a significant decrease in TJ expression, TEER, and ciliary beating efficiency in HNECs. After 24 h, the wound repair rate was significantly higher in OSM-stimulated HNECs at 100 ng/mL. These results suggest that OSM could become a new target for monoclonal antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire Inflammation Tissus Epithéliaux et Cytokines (LITEC), UR15560, Université de Poitiers, F-86000 Poitiers, France.
- Service ORL, Chirurgie Cervico-Maxillo-Faciale et Audiophonologie, Centre Hospitalier Universitaire de Poitiers, F-86000 Poitiers, France.
- Centre Hospitalier Intercommunal de Créteil, Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, F-94010 Créteil, France.
- CNRS EMR 7000, F-94010 Créteil, France.
- INSERM, IMRB, Univ Paris Est Creteil, F-94010 Créteil, France.
- Service d'ORL, de Chirurgie Cervico Faciale, Hôpital Henri-Mondor, Assistance Publique des Hôpitaux de Paris, F-94010 Créteil, France.
ORCID-Profile: Florent Carsuzaa, Stéphane Tringali, Maxime Fieux
Zitieren
APA
Carsuzaa, F., Bequignon, E., Bartier, S., Coste, A., Dufour, X., Bainaud, M., Lecron, J. C., Louis, B., Tringali, S., Favot, L., & Fieux, M. (2023). Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences, 24(7), 6094. https://doi.org/10.3390/ijms24076094
Vancouver
Carsuzaa F, Bequignon E, Bartier S, Coste A, Dufour X, Bainaud M, et al. Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences. 2023;24(7):6094. doi:10.3390/ijms24076094
BibTeX
@article{Carsuzaa2023,
author = {Carsuzaa, Florent and Bequignon, Emilie and Bartier, Sophie and Coste, André and Dufour, Xavier and Bainaud, Matthieu and Lecron, Jean Claude and Louis, Bruno and Tringali, Stéphane and Favot, Laure and Fieux, Maxime},
title = {Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6094},
doi = {10.3390/ijms24076094}
}
EUVIMED